Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-lin Lin

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Medical Oncology (Northwood, London, England)|April 2, 2016
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancerKuo-Hsing Chen, Yu-Lin Lin, Jau-Yu Liau, et al.
Plos One|February 8, 2014
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patientsYu-Lin Lin, Yi-Hsin Liang, Jia-Huei Tsai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2014
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancerJih-Hsiang Lee, Yu-Lin Lin, Wei-Hsun Hsu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2011
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II studyHui-Ju Ch'ang, Yu-Lin Lin, Hsiu-Po Wang, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Medical Oncology (Northwood, London, England)|April 2, 2016
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancerKuo-Hsing Chen, Yu-Lin Lin, Jau-Yu Liau, et al.
Plos One|February 8, 2014
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patientsYu-Lin Lin, Yi-Hsin Liang, Jia-Huei Tsai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2014
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancerJih-Hsiang Lee, Yu-Lin Lin, Wei-Hsun Hsu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2011
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II studyHui-Ju Ch'ang, Yu-Lin Lin, Hsiu-Po Wang, et al.
Pageof 7